MedTrace Logo

Memory Aid for Informed Consent in Alzheimer's Research

NCT00105612 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2009-12-29

No results posted yet for this study

Summary

The purpose of this trial is to test whether a memory and organizational aid in the form of a document that summarizes and simplifies a study's key points can improve the decision-making abilities and competency of mild to early moderate Alzheimer's disease (AD) patients.

Conditions

Interventions

DEVICE

Memory and Organizational Aid

BEHAVIORAL

Standard Informed Consent Process

The informed consent protocol for a hypothetical early-phase drug trial will be administered by a trained interviewer in the patient's home

Sponsors & Collaborators

  • National Institute on Aging (NIA)

    lead NIH

Principal Investigators

  • Jason Karlawish, MD · University of Pennsylvania Institute on Aging

Study Design

Allocation
RANDOMIZED

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00105612 on ClinicalTrials.gov